Furthermore, the substantial overexpression of CDC5L in cervical tumors, bladder cancer, gliomas, and osteosarcomas emphasizes its critical role in the pathogenesis of these cancers and its potential as a therapeutic target. Here, CDC5L is linked to uterine cervix neoplasm.